Extensive Hepatectomy as an Alternative to Liver Transplant in Advanced Hepatoblastoma: A New Protocol Used in a Pediatric Liver Transplantation Center
Carregando...
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
Citação
TRANSPLANTATION PROCEEDINGS, v.51, n.5, p.1605-1610, 2019
Resumo
Background. Surgery is a key factor in the treatment of hepatoblastoma, but choosing between an aggressive resection and liver transplant may be an extremely difficult task. The aim of this study was to describe the outcomes of patients with advanced hepatoblastoma: pretreatment extent of disease (PRETEXT)/post-treatment extent of disease (POST-TEXT) III and IV undergoing aggressive resections or living donor liver transplant in cases involving the entire liver. Based on this experience, a new protocol for the treatment of these patients was proposed. Methods. A retrospective study included patients with advanced hepatoblastoma (POST-TEXT III and IV) who were referred for a liver transplant from 2010 to 2017. Results. A total of 24 children were included: 13 (54.2%) were male, with a median age at diagnosis of 42 months (range, 15-120 months), and a history of prematurity was identified in 20.8% of the patients. Ten cases (41.7%) were staged as PRETEXT/POST-TEXT III, and 12 cases (50.0%) were staged as PRETEXT/POST-TEXT IV. Two patients were referred after posthepatectomy recurrence. Five patients underwent a liver transplant, with recurrence and death in 2 patients (40.0%) within a mean period of 6 months. In the extensive hepatectomy group, there was recurrence in 6 patients (31.6%), with disease-free outcomes and overall survival in 63.2% and 94.7% of patients, respectively. Conclusion. In cases of advanced hepatoblastoma, an extensive surgical approach is a valuable option. The fact that the team was fully prepared to proceed with living donor liver transplant allowed the surgeon to be more aggressive and to switch to transplantation when resection was not possible.
Palavras-chave
Referências
- Andrade WDC, 2014, J PEDIATR SURG, V49, P525, DOI 10.1016/j.jpedsurg.2013.09.004
- Tannuri ACA, 2015, CLINICS, V70, P387, DOI 10.6061/clinics/2015(06)01
- Browne M, 2008, J PEDIATR SURG, V43, P1973, DOI 10.1016/j.jpedsurg.2008.05.031
- Caicedo LA, 2017, TRANSPLANT DIRECT, V3, DOI 10.1097/TXD.0000000000000685
- Czauderna P, 2014, CURR OPIN PEDIATR, V26, P19, DOI 10.1097/MOP.0000000000000046
- Darbari A, 2003, HEPATOLOGY, V38, P560, DOI 10.1053/jhep.2003.50375
- Dicken BJ, 2004, J PEDIATR SURG, V39, P721, DOI 10.1016/j.jpedsurg.2004.01.035
- Fonseca A, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26820
- Fukuda A, 2014, TRANSPL P, V46, P1371, DOI 10.1016/j.transproceed.2013.12.054
- Kim T, 2012, TRANSPL P, V44, P523, DOI 10.1016/j.transproceed.2012.01.069
- Kremer N, 2014, CURR OPIN PEDIATR, V26, P362, DOI 10.1097/MOP.0000000000000081
- Lautz TB, 2011, CANCER-AM CANCER SOC, V117, P1976, DOI 10.1002/cncr.25722
- Lee CL, 1998, EUR J CANCER, V34, P2064, DOI 10.1016/S0959-8049(98)00281-0
- Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169
- Maibach R, 2012, EUR J CANCER, V48, P1543, DOI 10.1016/j.ejca.2011.12.011
- Meyers RL, 2014, CURR OPIN PEDIATR, V26, P29, DOI 10.1097/MOP.0000000000000042
- Pimpalwar AP, 2002, J PEDIATR SURG, V37, P240, DOI 10.1053/jpsu.2002.30264
- REYNOLDS M, 1992, J PEDIATR SURG, V27, P1080, DOI 10.1016/0022-3468(92)90564-N
- Roebuck DJ, 2007, PEDIATR RADIOL, V37, P123, DOI 10.1007/s00247-006-0361-5
- Suita S, 2004, J PEDIATR SURG, V39, P195, DOI 10.1016/j.jpedsurg.2003.10.012
- Watanabe K, 2013, INT J CLIN ONCOL, V18, P955, DOI 10.1007/s10147-013-0616-8